Latest news
Uganda launches Phase I clinical study of Bundibugyo virus disease vaccine
A Phase I clinical study has been launched evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV). The study is part of an international effort to develop vaccines against Ebola virus species for which no licensed vaccines are currently available.
Kenya confirms first imported Bundibugyo virus disease case; WHO supports control efforts
Following the confirmation by Kenyan authorities of the country’s first imported case of Bundibugyo virus disease (BVD), the World Health Organization (WHO) is working closely with the Government of Kenya to intensify key control measures to prevent further spread of the virus.
Reading the ocean’s snowflakes: How AI decodes marine snow
A constant snowfall of tiny particles drifts through the ocean, carrying carbon, nutrients and plastic toward the deep sea. Scientists are now developing AI tools that could reveal what this “marine snow” is made of simply by analyzing underwater images.
Rapid genomic test identifies fungal bloodstream infections
Researchers have developed a rapid genomic method that can identify fungal bloodstream infections at the species level in about seven hours. By combining host DNA depletion, whole-genome amplification and real-time nanopore sequencing, the approach could help clinicians select appropriate antifungal treatment much earlier.
Oncolytic viruses and CAR cells team up against solid tumors
Oncolytic viruses and CAR-T or CAR-NK cells could be engineered together to overcome some of the biggest barriers in solid tumor treatment. A new review outlines how these therapies may be combined into programmable systems that improve tumor targeting, immune-cell infiltration and sustained antitumor activity.
Chiba University and Noguchi Memorial Institute for Medical Research partnership targets next-generation vaccines
Chiba University and the University of Ghana’s Noguchi Memorial Institute for Medical Research have launched a new research partnership aimed at advancing next-generation vaccines, therapeutics and diagnostics. The collaboration will connect expertise in Japan and Ghana to strengthen infectious disease research, researcher training and global health innovation.
Reading the ocean’s snowflakes: How AI decodes marine snow
A constant snowfall of tiny particles drifts through the ocean, carrying carbon, nutrients and plastic toward the deep sea. Scientists are now developing AI tools that could reveal what this “marine snow” is made of simply by analyzing underwater images.
Oncolytic viruses and CAR cells team up against solid tumors
Oncolytic viruses and CAR-T or CAR-NK cells could be engineered together to overcome some of the biggest barriers in solid tumor treatment. A new review outlines how these therapies may be combined into programmable systems that improve tumor targeting, immune-cell infiltration and sustained antitumor activity.
American Academy of Pediatrics warns of dangers in consuming raw dairy products
Updated guidance warns that raw milk and other unpasteurized dairy products can expose children and pregnant people to serious infections, with H5N1 now emerging as an additional concern. Experts say pasteurisation provides the same nutritional benefits while dramatically reducing the risk from harmful bacteria and viruses.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
Sharpening an essential tool for biotechnology
Scientists develop a database of validated guide RNAs to improve engineering of microbes for manufacturing applications.
Green hydrogen production and storage using alcohols, iron, and baker’s yeast
A new recyclable system uses baker’s yeast to store H₂ in organic molecules and iron ions to release it when needed - offering a promising route toward more sustainable hydrogen production and storage.
Rapid genomic test identifies fungal bloodstream infections
Researchers have developed a rapid genomic method that can identify fungal bloodstream infections at the species level in about seven hours. By combining host DNA depletion, whole-genome amplification and real-time nanopore sequencing, the approach could help clinicians select appropriate antifungal treatment much earlier.
Scientists use bacteria to produce muconic acid from plants
Researchers have engineered a soil bacterium to synthesize muconic acid, a valuable chemical in the manufacturing industry, from plant matter.
Scientists mine fragmented data for antibiotics and cancer treatments
Researchers have developed a practical strategy for recovering biosynthetic information from fragmented metagenomic data. Through this work, the researchers identified and prioritized promising natural-product candidates with potential antibacterial or anticancer activity.
Uganda launches Phase I clinical study of Bundibugyo virus disease vaccine
A Phase I clinical study has been launched evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV). The study is part of an international effort to develop vaccines against Ebola virus species for which no licensed vaccines are currently available.
Kenya confirms first imported Bundibugyo virus disease case; WHO supports control efforts
Following the confirmation by Kenyan authorities of the country’s first imported case of Bundibugyo virus disease (BVD), the World Health Organization (WHO) is working closely with the Government of Kenya to intensify key control measures to prevent further spread of the virus.
Chiba University and Noguchi Memorial Institute for Medical Research partnership targets next-generation vaccines
Chiba University and the University of Ghana’s Noguchi Memorial Institute for Medical Research have launched a new research partnership aimed at advancing next-generation vaccines, therapeutics and diagnostics. The collaboration will connect expertise in Japan and Ghana to strengthen infectious disease research, researcher training and global health innovation.